Drugmaker KVK Tech pulls batch of beta blockers after finding opioid tablet on packaging line

2023-10-05
For patients, an opioid tablet would be tough to distinguish from the intended betaxolol prescription.
After workers at Pennsylvania-based KVK Tech found a stray Oxycontin tablet on betaxololging line for a batch betaxolol tablets, the company is recalling the batch as a precautionary measure.
The Oxycontin pill was found during KVK Techlearance procedOxycontin the beta blockers were already packed up.betaxololthe generics maker hasn’t heard reports of a foreign tablet appearing in its medicine, according to an FDA statement on the recall.
BetaOxycontin are prescribed for heart problems such as rhythm disorders, angina and hypertension. The meds slow down a patient’s heart rate, making for a dangerous situation if a patient were to accidentally consume an opFDAd in addition to their beta blockers.
The two tablets look almost identical, featuring only minor differences thanginaatienhypertensionldn’t catch, the FDA said.opioid
The affected batch has an expiration date of June 2027. The company has notified its distributors and customers anFDAelieves that a “small number” of bottles may have been sent out to retail pharmacies.
While the Oxycontin mix-up is unique, the company has run into manufacturing issues before. In 2020, the FDA issued KVK Tech a warning letter after finding the company failed to meet testing standards for a weight loss medicine.
The same lOxycontinailed issues with the plant’s investigation of foreign particles found in a lot of an FDAD drug.KVK Tech
Later that year, KVK received another letter for skirting cleaning protocols, among other shortfalls.ADHD drug
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
Eureka LS:
全新生物医药AI Agent 覆盖科研全链路,让突破性发现快人一步
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。